Speciality Medicines Ltd
Fri 18/09/2026,16:0:0 | BSE : SPML
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 150.00
Previous Close
₹ 150.00
Volume
3000
Mkt Cap ( ₹ Cr)
₹ 131.79
High
₹ 150.00
Low
₹ 150.00
52 Week High
₹ 381.20
52 Week Low
₹ 121.10
Book Value Per Share
₹ 81.03
Dividend Yield
₹ 0.00
Face Value
₹₹10.00
What's Your Call?
Collective community sentiment on Speciality Medicines Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Option Chain
Analyzes market sentiment, predicts Speciality Medicines Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Speciality Medicines - Reg. 34 (1) Annual Report.
-
Speciality Medicines - Notice Of 5Th Annual General Meeting
-
Speciality Medicines - Board Meeting Outcome for Outcome Of Board Meeting Held On September 03, 2026
-
Speciality Medicines - Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 Regarding Approval For Two New Pro
-
Speciality Medicines - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Speciality Medicines - Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 Regarding Appointment Of Investor
-
Speciality Medicines - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Key fundamentals
Evaluate the intrinsic value of Speciality Medicines Ltd stockÂ
| Name | March-26 | March-25 | March-24 | March-23 | |
|---|---|---|---|---|---|
| Assets | 77.8352 | 35.4633 | 17.9222 | 9.509 | |
| Liabilities | 77.8352 | 35.4633 | 17.9222 | 9.509 | |
| Equity | 8.7858 | 6.4358 | 5.1168 | 3.8201 | |
| Gross Profit | 13.6804 | 9.0921 | 5.2608 | 3.5655 | |
| Net Profit | 13.0329 | 8.6082 | 2.9336 | 1.6889 | |
| Cash From Operating Activities | -1.281 | -5.7944 | -4.8002 | -4.2148 | |
| NPM(%) | 17.31 | 14.77 | 10.65 | 7.26 | |
| Revenue | 75.2851 | 58.2714 | 27.5248 | 23.2408 | |
| Expenses | 61.6047 | 49.1793 | 22.264 | 19.6753 | |
| ROE(%) | 18.3 | 12.09 | 4.12 | 2.37 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Speciality Medicines Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 847.25 | -0.18 | 21.08 | 85.61 | -26.19 | 0.60 |
| Lotus Eye Hospital and Institute Ltd | 112.65 | -1.96 | 1644.29 | 311.94 | 0.39 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 14.16 | -2.95 | 0.00 | 647.70 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 732.00 | -3.29 | 0.00 | 334.23 | -363.14 | 0.00 |
Company Info
Our Company was originally incorporated as "Speciality Medicines Private Limited" as a Private Limited Company, under the provisions of the Companies Act, 2013 vide Certificate of Incorporation dated February 05, 2021, issued by the Registrar of Companies, Central Registration Centre. Later on, pursuant to a special resolution passed by our Shareholders in the ExtraOrdinary General Meeting held on April 04, 2024, our Company was converted from a private limited company to public limited company and consequently, the name of our Company was changed from "Speciality Medicines Private Limited" to "Speciality Medicines Limited" and a fresh certificate of incorporation dated June 25, 2024 was issued to our Company by the Registrar of Companies, Central Registration Centre. The Corporate Identification Number of our Company is U85300GJ2021PLC120022. MAJOR EVENTS:2021- Incorporation of our company viz. "Speciality Medicines Private Limited".- Our Company shifted its operation to Mumbai, Maharashtra, India2022- Our Company was recognized as Start-up by Department for Promotion of Industry and Internal Trade2023- Our Company received certificate as an eligible business by Inter-Ministerial Board to avail Income Tax benefits under Section 80-IAC of the Income Tax Act, 1961.2024- Conversion of our Company from Private Limited to Public Limited Company.
Our Company was originally incorporated as "Speciality Medicines Private Limited" as a Private Limited Company, under the provisions of the Companies Act, 2013 vide Certificate of Incorporation dated February 05, 2021, issued by the Registrar of Companies, Central Registration Centre. Later on, pursuant to a special resolution passed by our Shareholders in the ExtraOrdinary General Meeting held on April 04, 2024, our Company was converted from a private limited company to public limited company and consequently, the name of our Company was changed from "Speciality Medicines Private Limited" to "Speciality Medicines Limited" and a fresh certificate of incorporation dated June 25, 2024 was issued to our Company by the Registrar of Companies, Central Registration Centre. The Corporate Identification Number of our Company is U85300GJ2021PLC120022. MAJOR EVENTS:2021- Incorporation of our company viz. "Speciality Medicines Private Limited".- Our Company shifted its operation to Mumbai, Maharashtra, India2022- Our Company was recognized as Start-up by Department for Promotion of Industry and Internal Trade2023- Our Company received certificate as an eligible business by Inter-Ministerial Board to avail Income Tax benefits under Section 80-IAC of the Income Tax Act, 1961.2024- Conversion of our Company from Private Limited to Public Limited Company.
Read More
Parent Organisation
Speciality Medicines Ltd.
Founded
05/02/2021
Managing Director
Mr.Parthkumar Goyani
NSE Symbol
FAQ
The current price of Speciality Medicines Ltd is
The 52-week high for Speciality Medicines Ltd is
The market capitalization of Speciality Medicines Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Speciality Medicines Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Speciality Medicines Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Speciality Medicines Ltd shares.
The CEO of Speciality Medicines Ltd is Mr.Parthkumar Goyani, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
